VIR Past Earnings image   This VIR past earnings page last updated 5/24/2022
VIR Past Earnings
PeriodPast Earnings DateGAAP
Q1 20225/5/20223.850
Q4 20212/24/20223.920
Q3 202111/4/20210.820
Q2 20218/5/20210.460
Q1 20215/6/2021-1.320
Q4 20202/25/2021-0.830
Q3 202011/10/2020-0.670
Q2 20208/11/2020-0.270
Q1 20205/12/2020-0.710
Q4 20193/26/2020-0.710
Q3 201911/19/2019-4.600
VIR Past Revenue
PeriodPast Earnings DateGAAP
Q1 20225/5/20221.23B
Q4 20212/24/20220.81B
Q3 202111/4/20210.10B
Q2 20218/5/20210.18B
Q1 20215/6/20210.00B
Q4 20202/25/20210.00B
Q3 202011/10/20200.00B
Q2 20208/11/20200.07B
Q1 20205/12/20200.01B
Q4 20193/26/20200.00B
Q3 201911/19/20190.00B
Quotes delayed 20 minutes

Email EnvelopeFree VIR Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Vir Biotechnology (VIR) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

VIRI Historical Earnings
VIRX Historical Earnings
VIVE Historical Earnings
VIVO Historical Earnings
VKTX Historical Earnings
VLON Historical Earnings
VNDA Historical Earnings
VOR Historical Earnings
VRAY Historical Earnings
VRCA Historical Earnings

VIR Past Earnings Q&A

What was the best and worst VIR past earnings results?
For Vir Biotechnology, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest VIR past earnings result in our data set was 3.920/share posted in Q4 2021, while the lowest was in Q3 2019 when VIR posted -4.600/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q1 2022 when VIR reported 1.23B in revenue, while the quarter with the lowest revenue in our data set was Q4 2019 at 0.00B of revenue.

  Suggested answer: There are 11 VIR past earnings results in our data set.

On this page we presented the VIR past earnings date information for Vir Biotechnology. Reviewing that VIR Past Earnings for the company, we see that the highest past earnings result in our data set was in Q4 2021, when VIR posted gaap of 3.920/share. Meanwhile the lowest VIR past earnings result was in Q3 2019, when VIR posted gaap of -4.600/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q1 2022 when VIR reported 1.23B in revenue, while the smallest revenue quarter was Q4 2019 when VIR reported 0.00B in revenue.

Any self directed investor doing their due diligence on VIR or any other given stock can benefit from researching all of the Vir Biotechnology past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Vir Biotechnology past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for VIR. Thanks for visiting, and the next time you need to research VIR past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: VVC Videos, Funds Holding BRAC, Leveraged Technology ETFs.

 

VIR Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.